GAMA
ELV icon

Graticule Asia Macro Advisors’s Elevance Health ELV Stock Holding History

Graticule Asia Macro Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,800
Closed -$493K – 125
2018
Q3 		$493K Buy
+1,800
New +$467K 0.03% 176
2018
Q2 		– Sell
-1,000
Closed -$220K – 178
2018
Q1 		$220K Buy
+1,000
New +$235K 0.02% 140

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graticule Asia Macro Advisors's ELV Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 1,800 shares — an estimated $493K sold.

Graticule Asia Macro Advisors first reported a position in ELV in Q1 2018 and held it in 2 quarters. The position peaked at $493K in Q3 2018. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Graticule Asia Macro Advisors reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 1,800 Elevance Health shares in Q4 2018, an estimated $493K.
  • Graticule Asia Macro Advisors first reported a position in Elevance Health in Q1 2018 and held it in 2 quarters.
  • Graticule Asia Macro Advisors's Elevance Health position peaked at $493K in Q3 2018.
  • 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.